Table 2.
Results of ANCOVAs examining within-group changes in clinical indicators from baseline to months 4 and 10
| Month 4 assessmenta |
Month 10 assessmentb |
|||||
|---|---|---|---|---|---|---|
| n | Means (SD) at month 4 | Δ From baseline | n | Means (SD) at month 10 | Δ From baseline | |
| HbA1c (%) | ||||||
| Project Dulce | 64 | 9.0 (1.9) | −1.7* | 56 | 9.1 (2.0) | −1.5* |
| Control subjects | 81 | 9.1 (1.9) | −1.1 | 74 | 9.7 (2.3) | −0.8 |
| Total cholesterol (mg/dL) | ||||||
| Project Dulce | 64 | 183.3 (46.1) | −11.0 | 57 | 186.8 (44.4) | −7.2† |
| Control subjects | 81 | 187.0 (40.9) | −8.5 | 74 | 192.1 (51.9) | −2.4 |
| HDL (mg/dL) | ||||||
| Project Dulce | 64 | 47.3 (12.2) | +1.4† | 57 | 48.1 (11.7) | +1.6† |
| Control subjects | 82 | 46.8 (13.5) | +0.5 | 74 | 47.9 (14.6) | +1.7 |
| LDL (mg/dL) | ||||||
| Project Dulce | 60 | 99.1 (40.2) | −8.1 | 56 | 99.4 (36.3) | −8.1† |
| Control subjects | 80 | 104.3 (34.2) | −5.8 | 72 | 103.6 (37.7) | −7.2 |
| Triglycerides (mg/dL) | ||||||
| Project Dulce | 64 | 180.2 (103.7) | −28.7 | 56 | 182.3 (113.6) | −20.0 |
| Control subjects | 82 | 192.0 (89.1) | −8.4 | 73 | 198.6 (128.3) | +7.5 |
| Systolic blood pressure (mmHg) | ||||||
| Project Dulce | 65 | 119.6 (13.6) | −3.2 | 57 | 118.9 (14.8) | −2.5 |
| Control subjects | 82 | 121.7 (17.9) | +0.5 | 74 | 119.3 (16.6) | −1.6 |
| Diastolic blood pressure (mmHg) | ||||||
| Project Dulce | 65 | 73.1 (8.1) | −1.7 | 57 | 71.8 (8.0) | −2.2 |
| Control subjects | 82 | 74.7 (9.7) | −0.7 | 74 | 74.8 (8.1) | +0.5 |
| BMI | ||||||
| Project Dulce | 64 | 30.6 (6.0) | −0.1 | 57 | 30.9 (6.0) | −0.3 |
| Control subjects | 83 | 32.3 (6.3) | −0.1 | 74 | 31.7 (6.4) | −0.4 |
aValues reported for participants with baseline and month 4 values (total N: Project Dulce = 66; control subjects = 83; sample sizes for individual analyses are reduced as noted because of missing values).
bValues reported for participants with baseline and month 10 values (total N: Project Dulce = 58; control subjects = 75; sample sizes for individual analyses are reduced as noted because of missing values).
Change values are calculated using the baseline mean of the subset of participants who completed the follow-up under consideration. All analyses control for age and sex; however, unadjusted means are reported.
*P < 0.01.
†P < 0.05. Two-tailed P values pertain to tests of within-group changes from baseline.